MedPath

Brief Intervention for Drug Abusing Adolescents

Phase 2
Completed
Conditions
Drug Abuse
Interventions
Behavioral: brief intervention (cognitive-behavioral therapy)
Registration Number
NCT00350909
Lead Sponsor
University of Minnesota
Brief Summary

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Detailed Description

The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.

Specifically, we propose a randomized clinical trial to evaluate the efficacy of a cognitive-behavioral therapy on key process and outcome dimensions among school-based youth with mild-to-moderate drug abuse (MMDA). The experimental treatment is designated Brief Cognitive Behavioral Intervention (BCBI) given its theoretical foundation in stage of change theory used to coordinate modules on Rational-Emotive Therapy and Problem Solving Therapy. BCBI will be compared against a second experimental treatment that consists of BCBI and a single parent session (BCBI+P) and an assessment only condition (control). The importance of clarifying mechanisms in drug treatment research will be explored with respect to a limited number of treatment and individual factors that have emerged as promising mediating and moderating factors, such as cognitive and problem solving factors, parenting practices, and peer group influences.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  1. student at a local school
  2. meets DSM-IV criteria for a substance abuse disorder for at least one drug
  3. student and parent both agree to participate in the intervention study
Exclusion Criteria
  1. meets criteria for at least one DSM-IV substance dependence disorder
  2. meets criteria for a psychotic disorder or a learning disability

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1brief intervention (cognitive-behavioral therapy)One arm was a 2-session brief intervention with both sessions involving only the adolescent. Each session was a 60 minute individual session with the counselor.
2brief intervention (cognitive-behavioral therapy)The other arm was a 3-session brief intervention, with 2 sessions involving the adolescent and one session with the parent. Each of these individual sessions were 60 minutes.
Primary Outcome Measures
NameTimeMethod
Drug use frequency and quantity at 1-, 3- and 12-months post-intervention.1 year post treatment
Secondary Outcome Measures
NameTimeMethod
HIV and sexual risk behaviors at the same time period.1 year post treatment

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath